John C Jacobs insider trades

Open-market stock purchases and sales by John C Jacobs, President and CEO at Novavax Inc, from SEC Form 4 filings since Aug 18, 2020.

Recent trades

DateStockTradeValue
Mar 3, 2026NVAX Novavax IncSold (not open market)$658K
Mar 3, 2026NVAX Novavax IncBought (not open market)—
Mar 2, 2026NVAX Novavax IncBought (not open market)—
Mar 2, 2026NVAX Novavax IncBought (not open market)$5M
Mar 2, 2026NVAX Novavax IncBought (not open market)—
Mar 1, 2026NVAX Novavax IncSold (not open market)$390K
Mar 1, 2026NVAX Novavax IncBought (not open market)—
Jan 23, 2026NVAX Novavax IncSold (not open market)$359K
Jan 23, 2026NVAX Novavax IncBought (not open market)—

Companies traded

  • NVAX Novavax Inc: other filings, last Mar 3, 2026
  • HRMY Harmony Biosciences Holdings, Inc: 16 sales, last Aug 15, 2022

Get free alerts when John C Jacobs files a new trade →